Headlands Technologies LLC Purchases 25,626 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Key Points

• Headlands Technologies LLC significantly increased its position in Acadia Healthcare by 6,982.6%, owning 25,993 shares valued at approximately $788,000 by the end of the first quarter.
• Acadia Healthcare reported a net margin of 4.31% and revenue growth of 9.2% year-over-year, with EPS beating estimates at $0.83 for the latest quarter.
• Recent analyst reports have resulted in a decrease in stock price targets, with Barclays lowering theirs from $28.00 to $20.00, indicating a generally cautious outlook despite several buy ratings from other analysts.

Headlands Technologies LLC lifted its stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 6,982.6% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 25,993 shares of the company's stock after purchasing an additional 25,626 shares during the quarter. Headlands Technologies LLC's holdings in Acadia Healthcare were worth $788,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. FMR LLC raised its position in Acadia Healthcare by 257.9% in the fourth quarter. FMR LLC now owns 6,230,631 shares of the company's stock worth $247,045,000 after acquiring an additional 4,489,681 shares in the last quarter. Madison Avenue Partners LP bought a new stake in Acadia Healthcare in the fourth quarter worth about $76,339,000. Sachem Head Capital Management LP bought a new stake in Acadia Healthcare in the fourth quarter worth about $52,734,000. Khrom Capital Management LLC bought a new stake in Acadia Healthcare in the fourth quarter worth about $49,602,000. Finally, Balyasny Asset Management L.P. bought a new stake in Acadia Healthcare in the fourth quarter worth about $43,092,000.

Wall Street Analyst Weigh In

Several equities research analysts have commented on ACHC shares. Wall Street Zen upgraded shares of Acadia Healthcare from a "sell" rating to a "hold" rating in a research report on Sunday, August 3rd. Guggenheim cut their price objective on Acadia Healthcare from $36.00 to $29.00 and set a "buy" rating on the stock in a report on Thursday, August 7th. Stephens upgraded Acadia Healthcare to a "hold" rating in a report on Monday, June 2nd. Cowen restated a "buy" rating on shares of Acadia Healthcare in a report on Thursday, August 7th. Finally, Royal Bank Of Canada set a $28.00 price objective on Acadia Healthcare and gave the stock an "outperform" rating in a report on Wednesday. Five investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $43.25.

Acadia Healthcare Stock Up 1.4%

NASDAQ:ACHC traded up $0.29 on Wednesday, hitting $20.62. 1,200,361 shares of the company's stock traded hands, compared to its average volume of 2,194,161. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.73. Acadia Healthcare Company, Inc. has a 1 year low of $17.13 and a 1 year high of $82.40. The firm has a 50-day moving average price of $22.08 and a 200-day moving average price of $27.42. The company has a market cap of $1.90 billion, a PE ratio of 13.72, a price-to-earnings-growth ratio of 3.71 and a beta of 0.88.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last released its earnings results on Tuesday, August 5th. The company reported $0.83 earnings per share for the quarter, beating the consensus estimate of $0.71 by $0.12. The company had revenue of $869.23 million for the quarter, compared to analysts' expectations of $839.59 million. Acadia Healthcare had a return on equity of 8.34% and a net margin of 4.31%. The business's revenue for the quarter was up 9.2% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.91 EPS. Equities analysts anticipate that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current fiscal year.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.